Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00054418
What this trial is testing

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Alliance for Clinical Trials in Oncology 216
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Post-approval studies (Phase 4)Study completedNCT00277160
What this trial is testing

Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Who this might be right for
NeutropeniaBreast CancerLung Cancer+2 more
Amgen 852
Testing effectiveness (Phase 2)Study completedNCT01448096
What this trial is testing

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse Lymphoma
Chonbuk National University Hospital 33
Not applicableUnknownNCT00426335
What this trial is testing

Evaluation of Group CBT Programme With Breast Cancer Patients

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 78
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Looking for participantsNCT04273061
What this trial is testing

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Who this might be right for
Breast CancerLung CancerGastrointestinal Cancer+6 more
British Columbia Cancer Agency 50
Early research (Phase 1)UnknownNCT02970786
What this trial is testing

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Who this might be right for
Neuroendocrine CarcinomaBreast CancerOvarian Cancer
Rigshospitalet, Denmark 10
Testing effectiveness (Phase 2)Study completedNCT01204242
What this trial is testing

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

Who this might be right for
Breast Cancer
University of Virginia 78
Post-approval studies (Phase 4)Study completedNCT02005770
What this trial is testing

Anesthesia and Circulating Tumor Cells in Breast Cancer

Who this might be right for
Female Breast Carcinoma
University of Zurich 221
Not applicableLooking for participantsNCT05071105
What this trial is testing

SBRT in Early Breast Cancer in Elderly Women

Who this might be right for
Breast Neoplasm Female
University of Rome Tor Vergata 30
Not applicableEnded earlyNCT03557554
What this trial is testing

Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy

Who this might be right for
Breast CancerNeuropathyNeuropathy;Peripheral
Bryan Schneider 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04298086
What this trial is testing

The Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Who this might be right for
Breast CancerPrimary Hormone Receptor Positive Breast Cancer
Memorial Sloan Kettering Cancer Center 43
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Not applicableNot Yet RecruitingNCT06744998
What this trial is testing

Hemopatch Implication After Axillary Dissection for Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 190
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01688609
What this trial is testing

Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer

Who this might be right for
HER2-positive Breast CancerStage II Breast CancerStage IIIA Breast Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)WithdrawnNCT02915172
What this trial is testing

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00330317
What this trial is testing

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 300
Next Page